Bio & Medical Technology Development Program

Directorate for National Strategic R&D Programs

Secure and support the commercialization of core original technology directly related to human life and health in the fields of bio and state-of-the-art medicine, such as new drugs and stem cells

Research areas: 11 areas, including the development of new drugs and next-generation medical technology

Eligibility: Researchers at universities, hospitals, and government-funded and private research institutes

Summary: Consists of 48 subcategory projects, including the development of new drug pipelines and next-generation medical equipment platform technology

Period: 2–10 years

Funding: KRW 100 million – 10 billion (USD 91 thousand – 9.09 million*) per project per year

* approximation based on exchange rate of 1 USD = 1,100 KRW

LIM, Moo Keun; Biotechnology Team 2 (mklim@nrf.re.kr)